{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:54:59Z","timestamp":1773885299514,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2023GXNSFBA026237"],"award-info":[{"award-number":["2023GXNSFBA026237"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460718"],"award-info":[{"award-number":["82460718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178422","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:43:34Z","timestamp":1764693814000},"page":"178422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting Skp2 by camptothecin induces p27 accumulation and confers drug resistance in non-small cell lung cancer"],"prefix":"10.1016","volume":"1011","author":[{"given":"Ming","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-En","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Ping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3826-6878","authenticated-orcid":false,"given":"Yong-Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178422_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JTO.0b013e31815efe24","article-title":"Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer-A time for excitement and equipoise","volume":"3","author":"Azzoli","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejphar.2025.178422_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2174\/0929867311320120006","article-title":"Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug","volume":"20","author":"Beretta","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178422_bib3","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.M301774200","article-title":"Role of the SCF ubiquitin ligase in the degradation of p21 in S phase","volume":"278","author":"Bornstein","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178422_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2020.01.013","article-title":"The Skp2 pathway: a critical target for cancer therapy","volume":"67","author":"Cai","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2025.178422_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/12013","article-title":"SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27","volume":"1","author":"Carrano","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178422_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","article-title":"Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer","volume":"18","author":"Chaft","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.178422_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","article-title":"Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression","volume":"154","author":"Chan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178422_bib8","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/cas.15005","article-title":"Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer","volume":"112","author":"He","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2025.178422_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.apsb.2018.07.008","article-title":"Recent developments in topoisomerase-targeted cancer chemotherapy","volume":"8","author":"Hevener","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2025.178422_bib10","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.178422_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13123079","article-title":"Targeting the ubiquitin-proteasome system for cancer therapeutics by small-molecule inhibitors","volume":"13","author":"LaPlante","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2025.178422_bib12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bmcl.2016.12.085","article-title":"The long story of camptothecin: from traditional medicine to drugs","volume":"27","author":"Martino","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2025.178422_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109875","article-title":"The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage","volume":"125","author":"Mei","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178422_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neo.2017.04.001","article-title":"The cell cycle inhibitors p21 and p27 control proliferation but enhance DNA damage resistance of glioma stem cells","volume":"19","author":"Morris-Hanon","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejphar.2025.178422_bib15","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.3390\/cancers13174363","article-title":"Apoptosis deregulation and the development of cancer multi-drug resistance","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2025.178422_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/MCB.01536-07","article-title":"p27 deficiency impairs G\/M arrest in response to DNA damage, leading to an increase in genetic instability","volume":"28","author":"Payne","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178422_bib17","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ijc.24621","article-title":"The reduction of cell death and proliferation by p27 minimizes DNA damage in an experimental model of genotoxicity","volume":"125","author":"Ranchal","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2025.178422_bib18","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1038\/onc.2017.64","article-title":"Skp2 deficiency restricts the progression and stem cell features of castration-resistant prostate cancer by destabilizing twist","volume":"36","author":"Ruan","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.178422_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/cbin.11779","article-title":"Inhibition of Skp2 enhances doxorubicin-induced cell death in B cell precursor acute lymphoblastic leukemia","volume":"46","author":"Shabestari","year":"2022","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejphar.2025.178422_bib20","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.3390\/ijms22136923","article-title":"The influence of cell cycle regulation on chemotherapy","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178422_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"P27, a novel inhibitor of G1 cyclin-cdk protein-kinase activity, is related to P21","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178422_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/cells10051147","article-title":"Emerging roles of SKP2 in cancer drug resistance","volume":"10","author":"Wu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.178422_bib23","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1038\/s41388-019-0955-7","article-title":"Skp2-mediated ubiquitination and mitochondrial localization of akt drive tumor growth and chemoresistance to cisplatin","volume":"38","author":"Yu","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.178422_bib24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s42003-023-05166-6","article-title":"Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells","volume":"6","author":"Zhou","year":"2023","journal-title":"Commun. Biol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:29:02Z","timestamp":1773865742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"alternative-id":["S0014299925011768"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178422","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Skp2 by camptothecin induces p27 accumulation and confers drug resistance in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178422"}}